Baah Michael Kwesi, Mensah Abraham Yeboah, Asante-Kwatia Evelyn, Amponsah Isaac Kingsley, Forkuo Arnold Donkor, Harley Benjamin Kingsley, Adjei Silas
Department of Pharmacognosy, Faculty of Pharmacy and Pharmaceutical Sciences, College of Health Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Department of Pharmacology, Faculty of Pharmacy and Pharmaceutical Sciences, College of Health Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Evid Based Complement Alternat Med. 2020 Apr 21;2020:8703197. doi: 10.1155/2020/8703197. eCollection 2020.
The emergence and resurgence of resistance to generations of antimalarial drugs have prompted the search for new, effective, and safe antimalarial agents. This study aimed at investigating the antiplasmodial activity of the 70% hydroethanolic extract and constituents of the stem bark of based on its ethnomedicinal use as an antimalarial agent. The antiplasmodial activity was assessed in Swiss albino mice employing the 4-day suppressive and Rane's tests. MLB significantly ( < 0.0001) suppressed parasitaemia by 52.26%, 65.40%, and 77.11% at 50, 100, and 200 mg·kg doses, respectively, in the 4-day suppressive test. In Rane's test, the highest parasitaemia suppression of 72.50% was recorded at a dose of 200 mg·kg of the extract. Fractionation of the bioactive ethyl acetate fraction by solvent-solvent partitioning and column chromatography led to the isolation of friedelan-3-one and stigmasterol being reported for the first time from this species. The compounds demonstrated remarkable antiplasmodial activity by suppressing parasitaemia by 65-72% in the suppressive test and 61-70% in the curative test at doses of 10-30 mg·kg. Both the extract and the isolated compounds significantly prolonged the survival time of infected mice and averted the cardinal signs associated with -induced malaria including weight loss, hypothermia, and haemolysis. The results obtained confirm the prospect of as an important source of new antimalarial compounds and justifies its folkloric use as an antimalarial agent.
对几代抗疟药物耐药性的出现和复发促使人们寻找新的、有效且安全的抗疟药物。本研究旨在基于其作为抗疟药物的民族药用用途,研究[植物名称]茎皮70%乙醇提取物及其成分的抗疟原虫活性。在瑞士白化小鼠中采用4天抑制试验和拉内试验评估抗疟原虫活性。在4天抑制试验中,[提取物名称]在50、100和200mg·kg剂量下分别显著(P<0.0001)抑制疟原虫血症52.26%、65.40%和77.11%。在拉内试验中,提取物在200mg·kg剂量下记录到最高疟原虫血症抑制率为72.50%。通过溶剂 - 溶剂分配和柱色谱对生物活性乙酸乙酯部分进行分馏,首次从该物种中分离出羽扇豆醇和豆甾醇。在抑制试验中,这些化合物在10 - 30mg·kg剂量下通过抑制疟原虫血症65 - 72%,在治疗试验中抑制61 - 70%,表现出显著的抗疟原虫活性。提取物和分离出的化合物均显著延长了感染小鼠的存活时间,并避免了与[感染源]诱导的疟疾相关的主要症状,包括体重减轻、体温过低和溶血。所获得的结果证实了[植物名称]作为新抗疟化合物重要来源的前景,并证明了其作为抗疟药物的民间用途的合理性。